Quanthealth

Developing a new drug is one of the most time-consuming and expensive processes in medicine. Despite billions in investment, many drugs fail during clinical trials. The Israeli startup QuantHealth has secured $45 million to expand its artificial intelligence platform, which aims to optimize the planning and execution of clinical trials.

QuantHealth, a company developing AI-based simulations for clinical trials, has raised $45 million in a Series B funding round. The total amount raised by the company has now reached $75 million.